81 related articles for article (PubMed ID: 20050947)
1. Gelatinase activities and haptoglobin concentrations in healthy and in degenerative articular cartilage of pigs.
Schulze Willbrenning G; Hiss S; Theune C; Mielenz M; Schellander K; Sauerwein H
J Anim Physiol Anim Nutr (Berl); 2010 Dec; 94(6):757-66. PubMed ID: 20050947
[TBL] [Abstract][Full Text] [Related]
2. Determination of MMP-2 and -9 activities in synovial fluid of horses with osteoarthritic and arthritic joint diseases using gelatin zymography and immunocapture activity assays.
Fietz S; Einspanier R; Hoppner S; Hertsch B; Bondzio A
Equine Vet J; 2008 May; 40(3):266-71. PubMed ID: 18089467
[TBL] [Abstract][Full Text] [Related]
3. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
[TBL] [Abstract][Full Text] [Related]
4. Effects of moving training on histology and biomarkers levels of articular cartilage.
Qi C; Changlin H
J Surg Res; 2006 Oct; 135(2):352-63. PubMed ID: 16904690
[TBL] [Abstract][Full Text] [Related]
5. Measuring gelatinase activity in colorectal cancer.
Baker EA; Leaper DJ
Eur J Surg Oncol; 2002 Feb; 28(1):24-9. PubMed ID: 11869009
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the clinical significance of gelatinase activity in patients with juvenile idiopathic arthritis using quantitative protein substrate zymography.
Peake NJ; Foster HE; Khawaja K; Cawston TE; Rowan AD
Ann Rheum Dis; 2006 Apr; 65(4):501-7. PubMed ID: 16150790
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
8. Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.
Zhang L; Shi J; Feng J; Klocker H; Lee C; Zhang J
Prostate Cancer Prostatic Dis; 2004; 7(4):327-32. PubMed ID: 15356679
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.
Tetlow LC; Adlam DJ; Woolley DE
Arthritis Rheum; 2001 Mar; 44(3):585-94. PubMed ID: 11263773
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobin stimulates the expression of matrix metalloproteinases, MMP-2 and MMP-9 by synovial cells: a possible cause of joint damage after intra-articular hemorrhage.
Tajima T; Yoshida E; Yamashita A; Ohmura S; Tomitaka Y; Sugiki M; Asada Y; Maruyama M
J Orthop Res; 2005 Jul; 23(4):891-8. PubMed ID: 16023005
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases in articular cartilage of temporomandibular and knee joints of mice during growth, maturation, and aging.
Gepstein A; Shapiro S; Arbel G; Lahat N; Livne E
Arthritis Rheum; 2002 Dec; 46(12):3240-50. PubMed ID: 12483728
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid.
Srinivas R; Sorsa T; Tjäderhane L; Niemi E; Raustia A; Pernu H; Teronen O; Salo T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):517-25. PubMed ID: 11346728
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases 2 and 9 in equine synovial fluids.
Clegg PD; Coughlan AR; Riggs CM; Carter SD
Equine Vet J; 1997 Sep; 29(5):343-8. PubMed ID: 9306059
[TBL] [Abstract][Full Text] [Related]
14. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
15. Ischemia-reperfusion injury stimulates gelatinase expression and activity in kidney glomeruli.
Caron A; Desrosiers RR; Langlois S; Béliveau R
Can J Physiol Pharmacol; 2005 Mar; 83(3):287-300. PubMed ID: 15870843
[TBL] [Abstract][Full Text] [Related]
16. Developmentally regulated expression of matrix metalloproteinases during fetal rat colon morphogenesis.
Kurakata H; Oka M; Matsubara Y; Niwa T; Utsunomiya H; Fujishiro M; Miki K; Fukamachi H; Kubota S; Ichinose M
Dev Growth Differ; 2008 Jan; 50(1):41-8. PubMed ID: 17986262
[TBL] [Abstract][Full Text] [Related]
17. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
[TBL] [Abstract][Full Text] [Related]
18. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.
Eagleton MJ; Peterson DA; Sullivan VV; Roelofs KJ; Ford JA; Stanley JC; Upchurch GR
J Surg Res; 2002 May; 104(1):15-21. PubMed ID: 11971672
[TBL] [Abstract][Full Text] [Related]
20. Characterization of matrix metalloproteinase-2 and matrix metalloproteinase-9 and their inhibitors in equine granulosa cells in vivo and in vitro.
Sessions DR; Vick MM; Fitzgerald BP
J Anim Sci; 2009 Dec; 87(12):3955-66. PubMed ID: 19684269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]